46 related articles for article (PubMed ID: 12969531)
1. Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis.
Azevedo Martins JM; Rabelo-Santos SH; do Amaral Westin MC; Zeferino LC
BMC Cancer; 2020 Jul; 20(1):660. PubMed ID: 32669083
[TBL] [Abstract][Full Text] [Related]
2. Expression and clinical significance of matrix metalloproteinase-9 in lymphatic invasiveness and metastasis of breast cancer.
Wu QW; Yang QM; Huang YF; She HQ; Liang J; Yang QL; Zhang ZM
PLoS One; 2014; 9(5):e97804. PubMed ID: 24845596
[TBL] [Abstract][Full Text] [Related]
3. Methodologic research on TIMP-1, TIMP-2 detection as a new diagnostic index for hepatic fibrosis and its significance.
Nie QH; Cheng YQ; Xie YM; Zhou YX; Bai XG; Cao YZ
World J Gastroenterol; 2002 Apr; 8(2):282-7. PubMed ID: 11925608
[TBL] [Abstract][Full Text] [Related]
4. The overexpression membrane type 1 matrix metalloproteinase is associated with the progression and prognosis in breast cancer.
Li Y; Cai G; Yuan S; Jun Y; Li N; Wang L; Chen F; Ling R; Yun J
Am J Transl Res; 2015; 7(1):120-7. PubMed ID: 25755834
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of Matrix Metalloproteinases in the Metastatic Cascade of Breast Cancer to the Brain.
Kamalabadi Farahani M; Atashi A; Bitaraf FS
Asian Pac J Cancer Prev; 2023 Sep; 24(9):2997-3001. PubMed ID: 37774050
[TBL] [Abstract][Full Text] [Related]
6. Exploring Potential Biomarkers in Oesophageal Cancer: A Comprehensive Analysis.
Romanowicz A; Lukaszewicz-Zajac M; Mroczko B
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673838
[TBL] [Abstract][Full Text] [Related]
7. Further structural optimization and SAR study of sungsanpin derivatives as cell-invasion inhibitors.
Chen S; Zhang K; Zou J; Yu Z; Gai C; Chai X; Zhao Q; Zou Y
Bioorg Med Chem Lett; 2024 Feb; 99():129627. PubMed ID: 38272189
[TBL] [Abstract][Full Text] [Related]
8. Body composition and serum levels of matrix metalloproteinase-9, adiponectin and AMP-activated protein kinase in breast cancer survivors.
Babaei Z; Parsian H; Korani B; Mostafazadeh A; Moslemi D
J Res Med Sci; 2022; 27():48. PubMed ID: 35968203
[TBL] [Abstract][Full Text] [Related]
9. Metalloproteinases 1 and 3 as Potential Biomarkers in Breast Cancer Development.
Argote Camacho AX; González Ramírez AR; Pérez Alonso AJ; Rejón García JD; Olivares Urbano MA; Torné Poyatos P; Ríos Arrabal S; Núñez MI
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445715
[TBL] [Abstract][Full Text] [Related]
10. Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis.
Jiang H; Li H
BMC Cancer; 2021 Feb; 21(1):149. PubMed ID: 33568081
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteases and TIMPs as prognostic biomarkers in breast cancer patients treated with radiotherapy: A pilot study.
Olivares-Urbano MA; Griñán-Lisón C; Zurita M; Del Moral R; Ríos-Arrabal S; Artacho-Cordón F; Arrebola JP; González AR; León J; Antonio Marchal J; Núñez MI
J Cell Mol Med; 2020 Jan; 24(1):139-148. PubMed ID: 31568637
[TBL] [Abstract][Full Text] [Related]
12. The impact of matrix metalloproteinase 2 on prognosis and clinicopathology of breast cancer patients: a systematic meta-analysis.
Chen Y; Wang X; Chen G; Dong C; Zhang D
PLoS One; 2015; 10(3):e0121404. PubMed ID: 25816052
[TBL] [Abstract][Full Text] [Related]
13. Association of Fascin and matrix metalloproteinase-9 expression with poor prognostic parameters in breast carcinoma of Egyptian women.
Youssef NS; Hakim SA
Diagn Pathol; 2014 Jul; 9():136. PubMed ID: 24993803
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and aminopeptidase N/CD13 in breast cancer patients.
Ranogajec I; Jakić-Razumović J; Puzović V; Gabrilovac J
Med Oncol; 2012 Jun; 29(2):561-9. PubMed ID: 21611838
[TBL] [Abstract][Full Text] [Related]
15. MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factors.
Jinga DC; Blidaru A; Condrea I; Ardeleanu C; Dragomir C; Szegli G; Stefanescu M; Matache C
J Cell Mol Med; 2006; 10(2):499-510. PubMed ID: 16796815
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of matrix degrading enzymes and invasion in human glioblastoma (U87MG) cells by isoflavones.
Puli S; Lai JC; Bhushan A
J Neurooncol; 2006 Sep; 79(2):135-42. PubMed ID: 16598420
[TBL] [Abstract][Full Text] [Related]
17. [Expression and clinical significance of MMP-2, MMP-9,TIMP-1, and TIMP-2 in breast carcinoma].
Fan SQ; Wei QY; Li MR; Zhang LQ; Liang QC
Ai Zheng; 2003 Sep; 22(9):968-73. PubMed ID: 12969531
[TBL] [Abstract][Full Text] [Related]
18. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
Wei QY; Wu YQ; Fan SQ
Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
[TBL] [Abstract][Full Text] [Related]
19. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
